Tag: AI
BRAIN.Q achieves CE mark of “breakthrough therapy” for reducing disability following...
BRAIN.Q has announced that the CE mark has been granted for its BQ 2.0 system, which is designed to reduce disability following ischaemic stroke.
A...
US FDA issues first draft guidance for AI-based medical device development
The US Food and Drug Administration (FDA) has issued draft guidance that includes recommendations to support development and marketing of safe and effective artificial...
Viz.ai announces integration of Avicenna.AI’s CINA-ASPECTS stroke severity assessment tool
Leading artificial intelligence (AI)-based medical imaging companies Viz.ai and Avicenna.AI have announced the integration of Avicenna.AI’s CINA-iPE and CINA-ASPECTS tools into Viz.ai’s One platform....
New Viz.ai data indicate fewer futile transfers and substantial cost savings...
Viz.ai has announced clinical data validating the impact of Viz LVO in the management and outcomes of patients with large vessel occlusion (LVO) ischaemic...
Oxford Heartbeat completes patient recruitment in trial evaluating PreSize Neurovascular software
Oxford Heartbeat has today announced that the clinical impact trial of its artificial intelligence (AI)-powered PreSize Neurovascular software has successfully completed patient recruitment.
A company press release...
RapidAI and Alaska Stroke Coalition partner to overcome distance and other...
RapidAI and the Alaska Stroke Coalition (ASC) have announced their partnership on the ‘Rapid AK’ project—a three-year initiative focused on advancing health equity for...
Gravity launches Supernova stent retriever and Neutron aspiration catheter for global...
Gravity Medical Technology has announced the launch of its next-generation stroke treatment devices: the Neutron aspiration catheter and the Supernova stent retriever. Early adoption...
Brainomix announces presentation of US data validating AI technology in stroke...
Brainomix has announced new data from studies that were presented this week at the Society of NeuroInterventional Surgery (SNIS) annual meeting (22–26 July, Colorado...
Avicenna.AI secures European MDR certification for AI medical imaging portfolio
Avicenna.AI has received Medical Device Regulation (MDR) certification for five of its algorithms from British Standards Institution (BSI) Medical Devices—a development that means the...
Researchers highlight potential for autonomous stroke thrombectomy treatments in new paper
The use of robots in the autonomous treatment of stroke patients could widen access to time-sensitive emergency mechanical thrombectomy procedures, as evidenced by a...
ARISE I recommends multidisciplinary approach to managing brain aneurysms, chronic SDHs...
Three papers published in the journal Stroke have highlighted multidisciplinary care and global, collaborative efforts as “paramount” in the management of intracranial aneurysms, chronic...
RapidAI secures US FDA clearance for perfusion imaging tool within angio...
RapidAI has announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance for its AngioFlow by RapidAI solution. As per a company press...
Viz.ai and Nico announce collaboration to improve interventional ICH outcomes
Viz.ai has announced a collaboration with Nico Corporation to improve the lives of patients with intracranial haemorrhages (ICHs), leveraging the former’s artificial intelligence (AI)-powered...
XCath highlights endovascular robotics innovation at SLICE Next Frontiers
XCath has announced that it presented at the recent Stroke Live Course (SLICE) Next Frontiers conference (3–4 April, virtual), hosted by Vincent Costalat (University Hospital...
AI language model shows “encouraging” potential in locating brain lesions after...
Artificial intelligence (AI) may serve as a future tool for neurologists to help locate the part of the brain in which a stroke occurred,...
RapidAI highlights TIMELESS trial publication among other key ISC 2024 presentations
RapidAI has announced the publication of TIMELESS—a randomised trial evaluating the use of tenecteplase in acute ischaemic stroke treatment—in the New England Journal of Medicine...
AI-based decision support system helps improve post-stroke vascular outcomes at three...
Ischaemic stroke survivors who received care recommendations from an artificial intelligence (AI)-based system experienced fewer recurrent strokes and heart attacks, and a lower rate...
New UK NICE guidance endorses AI-derived software in stroke assessments
A new guidance document from the UK National Institute of Health and Care Excellence (NICE) has endorsed National Health Service (NHS) deployment of two...
GE HealthCare to acquire AI-imaging specialist
GE HealthCare has entered into an agreement to acquire MIM Software, a provider of artificial intelligence (AI)-enabled image analysis and workflow tools across multiple...
Researchers receive €10 million grant to create ‘digital twins’ in cerebral...
Researchers in The Netherlands have received a Horizon grant worth €10 million from the European Commission to accelerate development of a technology that could...
Recruitment in UK trial evaluating PreSize Neurovascular software reaches halfway point
Oxford Heartbeat has announced that its ongoing clinical impact trial of PreSize Neurovascular—a CE mark-certified, “first of its kind” for decision-support software in the field that...
Nicolab attains US FDA 510(k) clearance for CT perfusion algorithm
Nicolab has announced that its computed tomography (CT) perfusion algorithm, which is integrated into the company’s StrokeViewer platform, has obtained 510(k) clearance from the...
Brainomix targets US expansion following launch of 360 platform at SVIN...
Brainomix has heralded its continued US expansion with the launch of a full suite of US Food and Drug Administration (FDA)-cleared modules in its...
Brainomix and Nanoflex to work on AI-assisted robotic system for remote...
Brainomix and Nanoflex Robotics have announced today that they have been awarded a grant via the ‘UK—Switzerland Bilateral: Collaborative R&D ’ programme, under which...
Hyperfine gains US FDA clearance for AI-powered software update of Swoop...
Hyperfine has announced US Food and Drug Administration (FDA) clearance of updated software for its portable magnetic resonance brain imaging technology, the Swoop system....
AI algorithm shows promise for early intracerebral haemorrhage detection in retrospective...
Sheba Medical Center in Tel Aviv, Israel has revealed the results from a “groundbreaking” study in the International Journal of Emergency Medicine, validating an...
Report finds improved thrombectomy access at NHS hospitals using Brainomix’s AI...
More stroke patients are benefitting from life-changing treatment thanks to Brainomix's e-Stroke artificial intelligence (AI) platform, according to a recent report from the Oxford...
Viz.ai announces study findings demonstrating real-world impact of AI-driven stroke technology
Viz.ai has announced the presentation of three new abstracts that demonstrate the real-world impact of the Viz neuro suite at this week’s Society of...
Aidoc launches AI-powered Full Brain solution to “significantly expand” stroke detection
Aidoc has announced the launch of its “revolutionary” Full Brain solution, which the company claims will significantly expand the anatomy analysed by artificial intelligence...
Nicolab and Titan partner to improve prehospital workflows in acute stroke
Nicolab and Titan Neuroscience Research Australia have announced the formal signing of a Memorandum of Understanding (MOU) between the two organisations. The MOU outlines...
RapidAI announces US$75 million growth investment led by Vista Credit Partners
RapidAI today announced US$75 million in Series C funding led by Vista Credit Partners, a subsidiary of Vista Equity Partners and strategic financing partner focused on the...
‘Intelligent suit’ supported by AI and electrical stimulation could enhance spinal...
Experts in Germany are working on an ‘intelligent suit’ with which they hope to significantly improve rehabilitation after a serious spinal cord injury. This...
Zeta Surgical announces successful first treatment in neurosurgical navigation study
Zeta Surgical has successfully treated its first patient using the Zeta cranial navigation system as part of a first-in-human trial at the National Neuroscience Institute (NNI)...
LINNC 2023 examines neuroprotection, steerable microcatheters and other ‘next frontiers’
Neuroprotective agents and steerable microcatheter technologies were among a number of potential new interventional neuroradiology (INR) frontiers showcased and discussed at this year’s LINNC...
Sensome and Asahi Intecc partner to further development of Clotild smart...
Sensome and Asahi Intecc have today announced a collaboration to develop the next-generation Clotild smart guidewire, with Asahi Intecc taking on the manufacturing role...
Nicolab awarded three-year contract to supply AI-powered stroke software in Australia
Nicolab has been awarded a prestigious three-year contract to supply stroke workflow software and advanced artificial intelligence (AI) diagnostics for the Victorian Stroke Telemedicine...
AI tool outperforms human emergency call handlers in identifying stroke
A team of researchers from Denmark have developed a new artificial intelligence (AI) framework to address the number of strokes that go unrecognised by...
ChatGPT outperforms medical students and matches residents on neurosurgical board-style questions
An analysis published in the Journal of Neurosurgery, which assessed ChatGPT’s (OpenAI) performance on a surrogate for neurosurgical board-style questions, has found that the...
RapidAI wins MedTech Breakthrough award for best new imaging solution
RapidAI announced recently that its combined haemorrhagic solution—Rapid ICH (intracranial haemorrhage) and Rapid Hyperdensity—has been selected as the “Best New Imaging Solution” in the...
Computing the future: Exploring ChatGPT’s potential role in neurosurgical practice
Brian Fiani (Livonia, USA) and Ryan Jarrah (Rochester, USA) take a look at the neurosurgical implications of one of the hottest topics permeating not...
ConcertAI’s TeraRecon announces release of AI-driven Neuro Suite
ConcertAI's TeraRecon has announced the release of Neuro Suite, its artificial intelligence (AI)-driven clinical suite, which the company claims is purpose-built for disease triage,...
Annalise.ai gains seven new 510(k) clearances for brain and chest imaging...
Annalise.ai has received US Food and Drug Administration (FDA) 510(k) clearances covering an additional seven findings as part of the company's innovative artificial intelligence...
Vitor Mendes Pereira
As medical accolades go, performing the world’s first robot-assisted neurointerventional procedure—a feat that Vitor Mendes Pereira and his team achieved back in 2019—is something...
Brainomix receives US FDA clearance for flagship stroke AI imaging software
Brainomix has today announced that its 360 e-ASPECTS tool for stroke has received US Food and Drug Administration (FDA) clearance, enabling the company to...
NovaSignal announces donation of NovaGuide 2 intelligent ultrasound system to Jacobs...
NovaSignal has today announced the donation of a NovaGuide 2 intelligent ultrasound system to the Jacobs Institute in Buffalo, USA in order to advance stroke...
Methinks receives CE-mark certification for AI-based stroke triage software
Methinks has announced receipt of a CE mark for its artificial intelligence (AI)-based medical imaging software, Methinks Stroke Suite, following a milestone year of...
Incepto partners with Avicenna.AI to improve stroke management in Europe
Incepto, a distributor and co-creator of artificial intelligence (AI) solutions applied to medical imaging, has signed a partnership with Avicenna.AI to enrich its platform...
Viz.ai collaborates with Johns Hopkins to expedite patient enrolment in brain...
Viz.ai has announced a collaboration with BIOS Clinical Trials Coordinating Center (BIOS CTTC) at Johns Hopkins University (Baltimore, USA) to expedite patient enrolment for...
Avicenna.AI announces total funding of US$10 million after securing Series A...
Avicenna.AI announced today that it has secured a Series A funding round, bringing aggregated investment in the company close to US$10 million. The round...
Blackford and Brainomix announce partnership to advance AI-assisted stroke care
Blackford—an artificial intelligence (AI) imaging platform and solutions provider—is set to form a strategic partnership with Brainomix to bring the latter’s comprehensive e-Stroke solution...
Challenging the status quo in stroke care
This advertorial is sponsored by Philips.
Time is of the essence when treating a patient who has just experienced a stroke. Every minute counts, and...
Stroke community intensifies efforts to tackle “unacceptable” disparities in thrombectomy access
A wealth of new data confirming the beneficial role mechanical thrombectomy can play in the treatment of acute ischaemic stroke came to light through...
AI demonstrates potential to detect carotid artery disease on duplex ultrasound
A prospective study has demonstrated the potential feasibility, applicability and accuracy held by artificial intelligence (AI) in the detection of carotid artery disease on...
Viz.ai partners with Cercare to support neurovascular clinical decision-making
Viz.ai has announced a partnership with Cercare Medical that will incorporate the latter’s Cercare Perfusion—a fully-automated, simple-to-use, patient-specific perfusion software—into the Viz artificial intelligence...
Aidoc secures new FDA clearances for neurovascular and cardiovascular detection tools
Aidoc has announced it has increased its total number of US Food and Drug Administration (FDA) clearances to 11 with the addition of two...
Viz.ai and Vastrax join forces to accelerate neurovascular clinical trial enrolment
Viz.ai has announced a strategic partnership with full-service, vascular clinical research organisation (CRO) Vastrax. Together, the two companies intend to accelerate clinical trial enrolment for...
Rapid ICH receives new US FDA clearance with “highest sensitivity and...
RapidAI has announced receipt of US Food and Drug Administration (FDA) 510(k) clearance for the latest release of Rapid ICH—a technology that it describes as...
Philips to highlight latest advances in stroke care at 2022 World...
Royal Philips today announced it will showcase the company’s latest advances to support the treatment of stroke patients at the 14th annual World Stroke...
RAPID Aneurysm programme shows positive early performance in retrospective study
RAPID Aneurysm, a semi-automated artificial intelligence (AI) software programme (RapidAI), is highly accurate in detecting cerebral aneurysms on computed tomography angiography (CTA) imaging, according...
How AI, automation, robotics and other innovations in ultrasound are improving...
Robert Hamilton (Los Angeles, USA) outlines several key milestones in the history of stroke care, and discusses how recent technological advances in this space...
Brainomix awarded tender to roll out AI imaging software across all...
Brainomix has announced that it has been awarded the national tender in Hungary to deploy its artificial intelligence (AI) stroke imaging software across all stroke centres...
SNIS 2022: Research shows AI-based stroke diagnostics can expand access to...
A new study presented at the Society of NeuroInterventional Surgery’s (SNIS) 19th annual meeting (25–29 July, Toronto, Canada) shows that artificial intelligence (AI) technology...
Viz.ai receives US FDA 510(k) clearance for Viz SDH, announces Hyperfine...
Viz.ai today announced it has received US Food and Drug Administration (FDA) 510(k) clearance for Viz Subdural (SDH). The Viz SDH algorithm uses artificial...
RapidAI receives US FDA clearance for Rapid Hyperdensity
RapidAI has announced receipt of US Food and Drug Administration (FDA) clearance for Rapid Hyperdensity—the newest addition to the RapidAI platform. According to the company,...
Robotics, AI and other innovations in stroke and aneurysm care on...
Specialists from around the world will gather at the Society of NeuroInterventional Surgery's (SNIS) 19th annual meeting (25–29 July, Toronto, Canada) next week to discuss...
AI-powered device delivers “amazing physiologic information” to guide thrombectomy treatments
The Clotild smart guidewire system (Sensome), which uses artificial intelligence (AI) to provide real-time insights on clot composition, is showing early promise in the...
Artificial intelligence tutoring outperforms expert instructors in neurosurgical training
Against the backdrop of remote learning technologies becoming increasingly important within medical training during the COVID-19 pandemic, a new study has found that—in a...
Avicenna.AI signs distribution agreement with Sectra for neurovascular AI solutions
Avicenna.AI has announced a signed distribution agreement with Sectra—an international medical imaging information technology (IT) and cybersecurity company. The agreement will see Avicenna’s AI...
Zeta Surgical secures US$5.2 million to enhance AI-driven neurosurgical technologies
Zeta Surgical has announced the close of US$5.2 million in seed financing—and will use these funds to finalise development of its neurosurgical navigation platform, Zeta,...
Pushing the boundaries of aneurysm detection, monitoring and care with AI
Alejandro Spiotta (Medical University of South Carolina, Charleston, USA) outlines what he believes could be the next frontier in cerebral aneurysm care—artificial intelligence (AI)—and...
AI, cost reductions and more represent bright future for neuromodulation industry
On technological and commercial fronts alike, the neuromodulation space is one of the more rapidly evolving subsectors within the medical industry—and has undergone a...
Viz.ai receives FDA 510(k) clearance for cerebral aneurysm detection algorithm
Viz.ai has received US Food and Drug Administration (FDA) 510(k) clearance for Viz ANEURYSM—a new algorithm that uses artificial intelligence (AI) to detect suspected...
RapidAI announces Karim Karti as new CEO
RapidAI has announced Karim Karti, former president and CEO of GE Healthcare Imaging, as the company’s chief executive officer (CEO).
“Karim’s tremendous global experience in...
Time savings, cost reductions and improved patient outcomes all key benefits...
Artificial intelligence (AI) and the role it can play in improving acute ischaemic stroke care protocols took centre stage at the Barts Research and...
AI holds the key to timely interventions in a field where...
This advertorial is sponsored by Nicolab.
In 2021, the Royal Infirmary of Edinburgh and networking hospitals are implementing StrokeViewer (Nicolab)—which is an artificial intelligence (AI)...
New study finds e-Stroke software shortens treatment times and improves functional...
A new study presented at the 13th World Stroke Congress (WSC 2021; 28–29 October, virtual) found that the implementation of Brainomix's e-Stroke software resulted in...
ESOC 2021: AI can calculate personalised risk of having another stroke
Artificial intelligence (AI) can be used to give stroke patients a personalised and more accurate assessment of their risk of suffering a recurrence, according...
Qure.ai lands second FDA clearance for AI-based brain scan technology
Qure.ai has announced US Food and Drug Administration (FDA) 510(k) clearance for its brain computed tomography (CT) quantification product qER-Quant. Clinicians in the USA...
Viz.ai receives CE mark to bring AI-powered stroke care software to...
Viz.ai has been awarded a CE mark for its artificial intelligence (AI)-powered stroke care software, affirming its conformity with European health, safety and environmental...
Sensome’s AI-powered stroke guidewire granted FDA Breakthrough Device designation
Sensome has announced its Clotild Smart Guidewire System—designed to improve the treatment of ischaemic stroke patients—has been granted a Breakthrough Device designation by the...
Medtronic, Viz.ai partner to bring “lifesaving” AI platform for stroke to...
Medtronic and Viz.ai have announced they are extending their successful US partnership to distribute Viz.ai’s "lifesaving" artificial intelligence (AI) software platform for stroke to...
BrainQ trial results show a potential reduction in disability after stroke
BrainQ, an Israeli start-up with an artificial intelligence- (AI) powered therapeutic platform, has announced the results from a randomised controlled trial (RCT), showing 77%...
Stryker partners with Brainomix for AI stroke software
Stryker has announced a new partnership with Brainomix that provides an option for European customers to purchase Brainomix’s e-Stroke software.
According to a press release...
PreSize Neurovascular software launched at first UK NHS hospital
Doctors at St George’s Hospital in London, UK are set to become the first within the UK National Health Service (NHS) to begin using Oxford Heartbeat’s...
RapidAI announces software approval for Medicare New Technology Add-on Payment
RapidAI states Rapid LVO is among the first software products to qualify for the New Technology Add-on Payment (NTAP).
NTAP is part of the CMS...
RapidAI receives FDA clearance of Rapid LVO for identification of suspected...
RapidAI has announced that Rapid LVO has received US Food and Drug Administration (FDA) clearance for detecting suspected large vessel occlusions (LVOs).
Rapid LVO helps...
Rapid ASPECTS receives CADx clearance from the FDA
RapidAI has announced that Rapid ASPECTS has received US Food and Drug Administration (FDA) clearance as the first neuroimaging analysis device in the CADx (computer-assisted...
Study shows novel AI technology is better predictor of stroke than...
Boston-based medical technology company Elucid Bio, maker of the Food and Drug Administration (FDA)-cleared and CE-marked vascuCAP software, announced Wednesday, July 1, that its...
Viz.ai adds new capabilities to its AI stroke platform
Viz.ai has launched the next generation of its synchronized care platform for stroke. Viz.ai incorporates cutting edge artificial intelligence with HIPAA-compliant communication to allow...
US FDA clears Aidoc’s complete AI stroke package
Aidoc has announced that the US Food and Drug Administration (FDA) has cleared its AI solution for flagging large vessel occlusion (LVO) in head...
Philips extends AI portfolio with launch of IntelliSpace AI Workflow Suite...
Philips announces the launch of IntelliSpace AI Workflow Suite to enable healthcare providers to seamlessly integrate AI applications into the imaging workflow. Part of...
Viz.ai launches a range of new AI features
Viz.ai has announced a number of new features at the Society of Vascular and Interventional Neurology (SVIN) annual meeting in Atlanta, USA (20–23 November,...
Although “unperfected”, AI has the potential to accelerate and synchronise stroke...
A recently published systematic review reveals that artificial intelligence (AI) is rapidly being used by major medical centres to identify large vessel occlusions (LVO)...
Brainomix AI software improves stroke treatment rates at Budapest University Hospital
On the 8th of November 2019, during a symposium at the annual meeting of the Hungarian Neuroradiology Society (MNRT) in Mátraháza, Hungary, Bence Gunda...
Guerbet signs agreement with icometrix for the distribution of icobrain, an...
Guerbet announces that it has signed an exclusive agreement with icometrix for the distribution in France, Italy and Brazil of icobrain, their Saas (Software...
New AI tool for detecting cerebral aneurysms enhances clinicians’ accuracy
Through developing a deep learning model to automatically detect clinically significant intracranial aneurysms on computed tomography (CT) angiography, clinicians’ sensitivity, accuracy, and interrater reliability...
